Fig. 5From: Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s diseaseEffect of the MG1363-pMG36e-GLP-1 on the relative abundance of gut microbial diversity at phylum level in feces of mice. The relative abundance of Firmicutes (a), Bacteroidetes (b), Proteobacteria (c), Cyanobacteria (d), Fusobacteria (e), Actinobacteria (f) in feces of mice.C, control group (n = 8); AD, LPS group (n = 5); AD-G, LPS + 109 CFU MG1363-pMG36e-GLP-1 group (n = 5); PD, MPTP group (n = 8); PD-G, MPTP + 109 CFU MG1363-pMG36e-GLP-1 group (n = 8). Data are presented as mean ± SD. *p < 0.05, **p < 0.01Back to article page